PHK
BCYC

Point72 Hong Kong’s Bicycle Therapeutics BCYC Stock Holding History

Point72 Hong Kong’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-8
Closed – – 1141
2020
Q1 		$0 Hold
8
– – ﹤0.01% 963
2019
Q4 		$0 Buy
+8
New +$72 ﹤0.01% 1157

Other funds holding BCYC

TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Point72 Hong Kong's BCYC Position: Q2 2020 in Review

Point72 Hong Kong sold out of Bicycle Therapeutics (BCYC) in Q2 2020, closing a stake of 8 shares.

Point72 Hong Kong first reported a position in BCYC in Q4 2019 and held it in 2 quarters. The position peaked at $0 in Q1 2020. 16 funds tracked by Wall St. Rank hold BCYC as of Q2 2020.

  • Point72 Hong Kong reported no remaining Bicycle Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Point72 Hong Kong sold 8 Bicycle Therapeutics shares in Q2 2020.
  • Point72 Hong Kong first reported a position in Bicycle Therapeutics in Q4 2019 and held it in 2 quarters.
  • Point72 Hong Kong's Bicycle Therapeutics position peaked at $0 in Q1 2020.
  • 16 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2020.

Based on Point72 Hong Kong's 13F filing for Q2 2020, filed 14 Aug 2020.